Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review. - Wikidata - awgldk - TriplyDB

Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review.

Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review.

http://www.wikidata.org/entity/Q38181169

about

Targeting glycogen metabolism in bladder cancer Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.Epidermal growth factor receptor inhibitor with fluorouracil, leucovorin, and irinotecan as an alternative treatment for advanced upper tract urothelial carcinoma: a case report Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer.MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma.Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?Cisplatin and Paclitaxel Alter the Expression Pattern of miR-143/145 and miR-183/96/182 Clusters in T24 Bladder Cancer Cells.Targeting the VEGF pathway in metastatic bladder cancer.Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.

P2860

Q27025144-F51AE6C6-F462-4D00-8033-22ED4C0BF1F1 Q28066155-4F10B853-D12B-471A-BE9A-641ADF9DF545 Q35016935-410894FA-E632-4F36-AE46-1B8FD7F02F8F Q35993293-D6371B87-898F-43BA-8379-3F1651384000 Q35998718-33798854-31EA-408B-B5E7-E53B46994C9E Q36305476-A36E5817-C8DF-4821-A156-E012E2E77EEB Q36838996-BEC50A79-1F43-4A67-BA5A-AB97AC810E3B Q37530344-16166D99-4881-4D8B-A0E3-14175F9557AC Q37700868-AE22DAAC-289C-4025-BD47-8A8DFCDC75FD Q38534167-6388025A-81B0-4BD1-A02C-BCA69DF7CF41 Q38735342-5884E10B-88DF-40D1-9DB5-1FB938B60770

P2860

Chemotherapeutic and targeted biological agents for metastatic bladder cancer: a comprehensive review.

http://www.wikidata.org/entity/Q38181169

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Chemotherapeutic and targeted ...... ancer: a comprehensive review.

@en

type

label

Chemotherapeutic and targeted ...... ancer: a comprehensive review.

@en

prefLabel

Chemotherapeutic and targeted ...... ancer: a comprehensive review.

@en

P1433

Q38181169-B3A38E24-BAA3-416C-924B-8006AF4D6068

P1476

Q38181169-DA15C1E4-5DD7-4360-8FDF-41E3739761D0

P2093

Q38181169-651ADF1A-7A3F-439B-83E4-492883D96F1C

Q38181169-73535F7A-4DC4-450F-970A-516F9864FEAA

Q38181169-7988C4B3-5BC6-4379-B616-5894D3023FF6

Q38181169-7B8C102F-66D6-411A-8FAA-5B61F232105F

Q38181169-9C524883-758A-4E50-A041-B030994D50AF

P2860

Q38181169-04064294-B709-4995-97A6-FCDC8D22600D

Q38181169-0A40ED60-8CB5-475D-B3A4-5C2FB6D90749

Q38181169-1CEE9AB8-FF40-4CB3-9F16-9C8F8D03B520

Q38181169-2848B95A-F4B2-4ADF-87C6-347AEA86B085

Q38181169-344C645D-92D5-431E-9A2C-78FBEC9BBA59

Q38181169-433FB875-0FD2-4FFD-976D-2C5AB2BA9AF4

Q38181169-44EECADA-8373-45BE-9378-98A4734DA31C

Q38181169-4EB679BF-6647-49CE-B0E7-D6E58BC36D00

Q38181169-5D9F97B6-CFE6-4848-B5CF-650822ACE788

Q38181169-637EE148-BD59-4D82-83CD-D756F8326BCD

P304

Q38181169-2CADF6F9-8805-4FDF-92DA-CD2FD7108B5E

P31

Q38181169-57A83C42-A40D-4C50-B2DE-99B650008848

P356

Q38181169-39CE0E32-AFBA-49DA-BD3F-3B48E5A34830

P433

Q38181169-4479587B-07B9-4AD2-BBBA-2E8FF3C5ED3A

P478

Q38181169-3E31334A-3D76-49DE-BD9E-7895F94B5FFB

P577

Q38181169-DB470013-A4CC-45FC-A900-CF1E49AA6357

P5875

Q38181169-6C6A8738-EF65-4837-B99E-C4CA53DD1E33

P698

Q38181169-99281F4E-A211-4820-893F-EAFCF93BB451

P921

Q38181169-F4656731-514B-4381-8D82-BAEA19DE28E8

P356

P1433

International Journal of Urology

P1476

Chemotherapeutic and targeted ...... ancer: a comprehensive review.

@en

P2093

Jocelyn Ko

http://www.w3.org/2001/XMLSchema#string

Nitin Verma

http://www.w3.org/2001/XMLSchema#string

Terence T Sio

http://www.w3.org/2001/XMLSchema#string

Uzair B Chaudhary

http://www.w3.org/2001/XMLSchema#string

Vinay K Gudena

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens.

Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group study.

Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers.

Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99).

Systemic chemotherapy in inoperable or metastatic bladder cancer.

Vinflunine -- an active chemotherapy for treatment of advanced non-small-cell lung cancer previously treated with a platinum-based regimen: results of a phase II study.

Combination chemothereapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck.

P304

630-637

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJU.12407

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259880646

http://www.w3.org/2001/XMLSchema#string

P698

24455982

http://www.w3.org/2001/XMLSchema#string

P921